Be Prepared if Your Infusion Center Gives Romosozumab (Evenity) for Osteoporosis

You'll see some postmenopausal women admitted on the new osteoporosis med romosozumab (Evenity, ee-VEN-ih-tee).

Romosozumab is an injectable monoclonal antibody that blocks sclerostin, a protein involved in bone metabolism. This leads to increased bone growth AND decreased bone breakdown.

Other osteoporosis meds do one or the other.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals